What is sicca syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

What is Sicca Syndrome?

Sicca syndrome is a clinical condition characterized by dryness of the eyes (xerophthalmia) and mouth (xerostomia), most commonly caused by immune-mediated damage to the lacrimal and salivary glands in Sjögren's syndrome, though it can result from multiple other etiologies including systemic sclerosis, amyloidosis, medications, and aging. 1

Core Clinical Features

Sicca syndrome presents with two cardinal symptoms:

  • Xerophthalmia (dry eyes): Reduced tear production leading to ocular discomfort, burning, foreign body sensation, and potential corneal damage
  • Xerostomia (dry mouth): Diminished saliva production causing difficulty swallowing, speaking, dental decay, and oral infections

The syndrome can extend beyond these classic features to include dryness of other mucosal surfaces such as the nose, throat, vagina, and skin 2.

Relationship to Sjögren's Syndrome

While sicca syndrome and Sjögren's syndrome are often conflated, they are not synonymous 3. Sjögren's syndrome is the most common cause of sicca syndrome, affecting over 95% of patients with this autoimmune disease 1. The clinical scenario in Sjögren's is dominated by sicca symptoms caused by immune-mediated glandular involvement, with focal lymphocytic infiltration of exocrine glands as the histological hallmark 1.

However, sicca syndrome represents a heterogeneous group of conditions 4. Recent cluster analysis has identified distinct phenotypes within sicca patients:

  • Patients with autoimmune features (highest autoantibody titers, extra-glandular manifestations)
  • Patients with objective dryness but no autoimmune features
  • Patients with predominantly somatic symptoms but limited objective dryness 4

Other Important Etiologies

Beyond Sjögren's syndrome, clinicians must consider:

  • Systemic sclerosis: Sicca occurs in up to 80% of SSc patients, often due to fibrosis of salivary glands rather than autoimmune overlap 5
  • Primary systemic amyloidosis: Amyloid deposition in salivary and lacrimal glands can cause sicca syndrome, particularly in patients presenting with sicca symptoms, proteinuria, and negative serology 3, 6
  • Medications: Anticholinergics, antihistamines, antidepressants, and antihypertensives
  • Aging: Age-related glandular dysfunction
  • Other autoimmune diseases: Rheumatoid arthritis, systemic lupus erythematosus

Seronegative Sicca Syndrome

A particularly challenging subset includes seronegative sicca patients who present with xerostomia and/or keratoconjunctivitis sicca but lack anti-SSA/SSB antibodies and don't fulfill classification criteria for primary Sjögren's syndrome 7. These patients:

  • May show focal lymphocytic sialadenitis on biopsy similar to Sjögren's
  • Can have elevated cytokines (BAFF, IFN-α) and novel autoantibodies suggesting subclinical autoimmunity
  • Experience significant symptom burden but remain excluded from most therapeutic trials
  • May later seroconvert or develop systemic features 7

Clinical Significance

The distinction between sicca syndrome and Sjögren's syndrome carries important prognostic implications. Sjögren's syndrome patients have a significantly higher incidence of developing lymphoma (2-5%) compared to other causes of sicca 1, 6. This makes accurate diagnosis critical for appropriate monitoring and management.

Sicca symptoms have a significant impact on health-related quality of life 1. The natural history shows that glandular dysfunction may remain stable for long periods (up to 12 years) with a chronic course, and no therapeutic intervention has been demonstrated to reverse glandular dysfunction or cure sicca symptoms 1.

Diagnostic Approach Pearls

When evaluating sicca syndrome, look for:

  • Red flags for amyloidosis: Periorbital purpura, "pinch" purpura, proteinuria with negative serology 3, 6
  • Autoimmune markers: Anti-SSA/Ro, anti-SSB/La antibodies, ANA, rheumatoid factor
  • Objective evidence of dryness: Schirmer's test, ocular staining score (OSS), unstimulated whole salivary flow (UWSF)
  • Systemic manifestations: Arthralgia, fatigue, Raynaud's phenomenon, lymphadenopathy
  • Histopathology: Minor salivary gland biopsy showing focal lymphocytic sialadenitis (focus score ≥1) in Sjögren's, or amyloid deposition in amyloidosis 1, 3

References

3
Research

Etiologies of the sicca syndrome: primary systemic amyloidosis and others.

International journal of dermatology, 1996

6
Research

Primary salivary gland amyloidosis causing sicca syndrome.

The Annals of otology, rhinology, and laryngology, 1992

Related Questions

How should I manage a patient with burning dry mouth who tested negative for Sjögren’s syndrome?
Can Sjögren's syndrome affect the kidneys?
Can Sjögren's syndrome cause facial swelling due to salivary gland enlargement?
Can Sjögren’s syndrome exacerbate existing allergic conditions or cause new IgE-mediated food allergies?
How should a 77-year-old woman with near-syncope, numbness on the soles of her feet, past medical history of Sjögren’s syndrome, rheumatoid arthritis, and osteoporosis, and who is taking prednisolone 20 mg sustained‑release (Coracten), hyaluronic‑acid eye drops (Hyback 0.15%), and losartan be evaluated and managed?
What is the prevalence of primary lactation failure caused by insufficient glandular breast tissue in postpartum women?
What is the significance of focal fatty infiltration of the liver, a probable gallbladder polyp, and a possible non‑mobile gallstone on imaging?
How long does clonidine extended-release (XR) take to work for ADHD symptoms?
In a patient with chronic heart failure, how long does plasma pro‑B‑type natriuretic peptide (pro‑BNP) remain elevated after a strenuous exercise session?
For ventriculoperitoneal (VP) shunting, what are the maximum acceptable cerebrospinal fluid (CSF) protein concentration and cell count?
How should I manage a patient with a GI-MAP stool panel showing high levels of Helicobacter pylori, Escherichia coli, Bacteroidetes, Firmicutes, Salmonella, fecal calprotectin, Fusobacterium spp., Enterococcus faecium, Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus spp.?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.